Edwards Lifesciences Corp. (EW - Free Report) was a big mover last session, as the company saw its shares rise 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $70.94 to $75.19 in the past one month.
In the last 30 days, the company has seen a seen 1 positive estimate revision, while the Zacks Consensus Estimate remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Edwards Lifesciences currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Some better-ranked stocks in the Med Products industry space include Enzymotec Ltd. (ENZY - Free Report) , Covidien plc , and Owens & Minor Inc. (OMI - Free Report) . While Enzymotec carries a Zacks Rank #1 (Strong Buy), Covidien and Owens & Minor hold a Zacks Rank #2 (Buy).
EDWARDS LIFESCIENCES CORP (EW - Free Report
) : Free Stock Analysis ReportENZYMOTEC LTD ORD (ENZY - Free Report
) : Free Stock Analysis ReportCOVIDIEN PLC NEW : Free Stock Analysis ReportOWENS & MINOR INC (OMI - Free Report
) : Free Stock Analysis ReportZacks Investment Research